CSL Mergers and Acquisitions Summary

Life ScienceCompany

CSL has acquired 3 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 2 assets.

CSL’s largest acquisition to date was in 2008, when it acquired Talecris Biotherapeutics Holdings Corp for $3.1B. It’s largest disclosed sale occurred in 2005, when it sold JRH Biosciences to Sigma-Aldrich for $370M. CSL has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to CSL’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity2
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 5

CSL

CSL Ltd.

45 Poplar Road,
Melobourne, VIC 3052
Australia,
61 3 9389 1911
www.csl.com

CSL is a manufacturer and marketer of pharmaceutical and diagnostic products, cell culture media and human plasma fractions. CSL was founded in 1916 and is based in Parkville, Australia.


M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.0/yr) # 2 - - - - - 2
vol $3.5B $3.5B
Sell (0.0/yr) # 2 - - - - - 2
vol $370M $370M
  4

Most Recent M&A

Company Date Value Type
Wuhan Biological Products Research Institute Co. Ltd. 2017-06-13 352M USD Divestiture
Wuhan, China · www.wibp.com.cn
Talecris Biotherapeutics Holdings Corp 2011-06-02 - Divestiture
Research Triangle Park, North Carolina · www.talecris.com
Talecris Biotherapeutics Holdings Corp 2008-08-12 3.1B USD Add-on Acquisition
Research Triangle Park, North Carolina · www.talecris.com
JRH Biosciences, Inc. 2005-02-28 370M USD Divestiture
Lenexa, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 3.5B (100%) 2 (100%) 370M (100%)
Total 2 $3.5B 2 $370M

By Geo

State/Country Buy Value Sell Value
United States 1 3.1B 2 370M
  North Carolina 1 3.1B 1 -
China 1 352M - -
Domestic - - - -
Cross-border 2 (100%) 3.5B (100%) 2 (100%) 370M (100%)
Total 2 $3.5B 2 $370M

Deal Values

buy # Total
> $1B 1 $3.1B
$100M to $1B 1 $352M
TOTAL $3.5B
Largest Talecris Biotherapeutics Holdings Corp
$3.1B (2008-08-12)
sell # Total
$100M to $1B 1 $370M
TOTAL $370M
Largest JRH Biosciences, Inc.
$370M (2005-02-28)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 181,403
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 172K M&A Transactions
  • 177K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.